Quest Diagnostics Inc. DGX
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-13T02:10:28.996Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T00:00:00.003441584Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T02:10:28.362136+00:00
Quest Diagnostics Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 269.67 | 28.7% | 4.3% | 248.87 | 34.8% | 4.7% |
| 25Δ | 268.08 | 29.0% | 3.9% | 251.17 | 34.2% | 4.1% |
| 30Δ | 266.49 | 29.3% | 3.5% | 252.97 | 33.5% | 3.6% |
| 35Δ | 264.91 | 29.5% | 3.1% | 254.77 | 32.9% | 3.1% |
| 40Δ | 263.32 | 29.8% | 2.7% | 256.57 | 32.2% | 2.6% |
| 45Δ | 261.74 | 30.1% | 2.3% | 258.37 | 31.5% | 2.1% |
| 50Δ | 260.15 | 30.4% | 1.9% | 260.19 | 31.0% | 1.7% |
| 55Δ | 258.77 | 29.5% | 1.7% | 262.10 | 31.9% | 1.5% |
| 60Δ | 257.41 | 28.6% | 1.5% | 264.02 | 32.9% | 1.3% |
| 65Δ | 256.04 | 27.6% | 1.3% | 265.93 | 33.8% | 1.1% |
| 70Δ | 254.68 | 26.7% | 1.1% | 267.84 | 34.7% | 0.9% |
| 75Δ | 253.32 | 25.7% | 0.8% | 269.76 | 35.7% | 0.7% |
| 80Δ | 251.96 | 24.8% | 0.6% | 273.36 | 37.5% | 0.5% |
20Δ
- Pseudo strike
- 269.67
- IV
- 28.7%
- B/E move
- 4.3%
- Pseudo strike
- 248.87
- IV
- 34.8%
- B/E move
- 4.7%
25Δ
- Pseudo strike
- 268.08
- IV
- 29.0%
- B/E move
- 3.9%
- Pseudo strike
- 251.17
- IV
- 34.2%
- B/E move
- 4.1%
30Δ
- Pseudo strike
- 266.49
- IV
- 29.3%
- B/E move
- 3.5%
- Pseudo strike
- 252.97
- IV
- 33.5%
- B/E move
- 3.6%
35Δ
- Pseudo strike
- 264.91
- IV
- 29.5%
- B/E move
- 3.1%
- Pseudo strike
- 254.77
- IV
- 32.9%
- B/E move
- 3.1%
40Δ
- Pseudo strike
- 263.32
- IV
- 29.8%
- B/E move
- 2.7%
- Pseudo strike
- 256.57
- IV
- 32.2%
- B/E move
- 2.6%
45Δ
- Pseudo strike
- 261.74
- IV
- 30.1%
- B/E move
- 2.3%
- Pseudo strike
- 258.37
- IV
- 31.5%
- B/E move
- 2.1%
50Δ
- Pseudo strike
- 260.15
- IV
- 30.4%
- B/E move
- 1.9%
- Pseudo strike
- 260.19
- IV
- 31.0%
- B/E move
- 1.7%
55Δ
- Pseudo strike
- 258.77
- IV
- 29.5%
- B/E move
- 1.7%
- Pseudo strike
- 262.10
- IV
- 31.9%
- B/E move
- 1.5%
60Δ
- Pseudo strike
- 257.41
- IV
- 28.6%
- B/E move
- 1.5%
- Pseudo strike
- 264.02
- IV
- 32.9%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 256.04
- IV
- 27.6%
- B/E move
- 1.3%
- Pseudo strike
- 265.93
- IV
- 33.8%
- B/E move
- 1.1%
70Δ
- Pseudo strike
- 254.68
- IV
- 26.7%
- B/E move
- 1.1%
- Pseudo strike
- 267.84
- IV
- 34.7%
- B/E move
- 0.9%
75Δ
- Pseudo strike
- 253.32
- IV
- 25.7%
- B/E move
- 0.8%
- Pseudo strike
- 269.76
- IV
- 35.7%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 251.96
- IV
- 24.8%
- B/E move
- 0.6%
- Pseudo strike
- 273.36
- IV
- 37.5%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 27.55% | |
| 28.06% | |
| 29.51% | |
| 24.54% | |
| 24.30% | |
| 24.86% | |
| 26.46% | |
| 25.25% | |
| 25.19% | |
| 26.11% |
Diagnostics & Research
DHR
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional,…
More →FLGT
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in…
More →GH
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood…
More →GRAL
GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics, particularly through its innovative blood tests designed for multi-cancer early detection…
More →ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe, the United States and…
More →IDXX
Description unavailable
More →